Agilon Health Inc. (AGL) Reports In-Line Q2 EPS; lowers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
agilon health Inc (AGL) PT Lowered to $4 at Deutsche Bank
August 8, 2024 4:08 PM EDTDeutsche Bank analyst George Hill lowered the price target on agilon health Inc (NYSE: AGL) to $4.00 (from $5.00) while maintaining a Hold rating.
The analyst comments "Another Revenue Miss: AGL reported Q2 results missing at the revenue line but making it up with the better-than-expected adjusted EBITDA. AGL reported total revenue of $1.48B (+38% yoy), below the... More
